Meeting
2023 ASCO Genitourinary Cancers Symposium
Neoadjuvant platinum-based chemotherapy for clinically node-positive penile squamous cell carcinoma: An international, multicenter, real-world study.
Authors
Kyle M. Rose
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Kyle M. Rose , Darren Sanchez , Arfa Mustasam , Reagan Sandstrom , Kathryn Marchetti , Niki Marie Zacharias , Lance C. Pagliaro , Constantine Alifrangis , Kelvin A. Moses , Maarten Albersen , Eduard Roussel , Viraj A. Master , Bassel Nazha , Tony Zhuang , Jeffrey S. Montgomery , Chris Protzel , Marcos Tobias Machado , Philippe E. Spiess , Curtis Alvin Pettaway , Jad Chahoud
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 9)
DOI
10.1200/JCO.2023.41.6_suppl.9
Abstract #
9
Poster Bd #
D14
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Comparative analysis of pembrolizumab and cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma: Real-world data.
First Author: Zahra Hamedi
Poster
2024 ASCO Genitourinary Cancers Symposium
MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab (Av) vs Av after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).
First Author: Shilpa Gupta
Poster
2023 ASCO Genitourinary Cancers Symposium
Occurrence and prognostic significance of different histology relative to urinary tract tumors: A SEER population-based study.
First Author: Haoyang Liu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Short- and long-term real-world survival for metastatic bile duct cancer, 2000 to 2018.
First Author: Sarah Jeanne Wood